Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Schaefer

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Journal of the International AIDS Society|July 13, 2023
Systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis to prevent HIV acquisitionLara Lorenzetti, Nhi Dinh, Ariane van der Straten, et al.
Trials|December 4, 2019
Improving risk perception and uptake of pre-exposure prophylaxis (PrEP) through interactive feedback-based counselling with and without community engagement in young women in Manicaland, East Zimbabwe: study protocol for a pilot randomized trialRanjeeta Thomas, Morten Skovdal, Matteo M Galizzi, et al.
Journal of the International AIDS Society|May 28, 2025
HIV post-exposure prophylaxis in community settings and by lay health workers or through task sharing: a systematic review of effectiveness, case studies, values and preferences, and costsCaitlin E Kennedy, Rahel Dawit, Ping Teresa Yeh, et al.
Sexually Transmitted Infections|June 19, 2024
Missed opportunities for guidance on sexually transmitted infection services: a global review of national HIV PrEP guidanceErica Spielman, Maeve B Mello, Robin Schaefer, et al.
AIDS (London, England)|September 29, 2022
Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxisAmrit Kaur Ahluwalia, Seth Inzaule, Rachel Clare Baggaley, et al.
AIDS (London, England)|September 2, 2025
Multisector global collaboration to advance the inclusion of pregnant and lactating people in HIV prevention researchRobin Schaefer, Breanne Lievense, Suzanne Day, et al.
Harm Reduction Journal|February 14, 2023
Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service deliveryGraham Shaw, Robin Schaefer, Heather-Marie A Schmidt, et al.
Drug Safety|January 28, 2025
Antiretroviral Use for HIV Prevention During Pregnancy: The Need to Strengthen Regulatory and Surveillance Systems in AfricaRobin Schaefer, L Donaldson, A Chigome, et al.
AIDS (London, England)|February 1, 2023
Safety and efficacy of long-acting injectable cabotegravir as preexposure prophylaxis to prevent HIV acquisitionVirginia A Fonner, Kathleen Ridgeway, Ariane van der Straten, et al.
The Lancet. Global Health|June 22, 2023
Strengthening the HIV prevention cascade to maximise epidemiological impact in eastern Zimbabwe: a modelling studyMichael Pickles, Simon Gregson, Louisa Moorhouse, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of the International AIDS Society|July 13, 2023
Systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis to prevent HIV acquisitionLara Lorenzetti, Nhi Dinh, Ariane van der Straten, et al.
Trials|December 4, 2019
Improving risk perception and uptake of pre-exposure prophylaxis (PrEP) through interactive feedback-based counselling with and without community engagement in young women in Manicaland, East Zimbabwe: study protocol for a pilot randomized trialRanjeeta Thomas, Morten Skovdal, Matteo M Galizzi, et al.
Journal of the International AIDS Society|May 28, 2025
HIV post-exposure prophylaxis in community settings and by lay health workers or through task sharing: a systematic review of effectiveness, case studies, values and preferences, and costsCaitlin E Kennedy, Rahel Dawit, Ping Teresa Yeh, et al.
Sexually Transmitted Infections|June 19, 2024
Missed opportunities for guidance on sexually transmitted infection services: a global review of national HIV PrEP guidanceErica Spielman, Maeve B Mello, Robin Schaefer, et al.
AIDS (London, England)|September 29, 2022
Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxisAmrit Kaur Ahluwalia, Seth Inzaule, Rachel Clare Baggaley, et al.
AIDS (London, England)|September 2, 2025
Multisector global collaboration to advance the inclusion of pregnant and lactating people in HIV prevention researchRobin Schaefer, Breanne Lievense, Suzanne Day, et al.
Harm Reduction Journal|February 14, 2023
Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service deliveryGraham Shaw, Robin Schaefer, Heather-Marie A Schmidt, et al.
Drug Safety|January 28, 2025
Antiretroviral Use for HIV Prevention During Pregnancy: The Need to Strengthen Regulatory and Surveillance Systems in AfricaRobin Schaefer, L Donaldson, A Chigome, et al.
AIDS (London, England)|February 1, 2023
Safety and efficacy of long-acting injectable cabotegravir as preexposure prophylaxis to prevent HIV acquisitionVirginia A Fonner, Kathleen Ridgeway, Ariane van der Straten, et al.
The Lancet. Global Health|June 22, 2023
Strengthening the HIV prevention cascade to maximise epidemiological impact in eastern Zimbabwe: a modelling studyMichael Pickles, Simon Gregson, Louisa Moorhouse, et al.
Pageof 4